
VP & Founding Team, VivoSense, Inc., #Analytics, for #Wearables Data, Digital Biomarkers in #Raredisease, Oncology, Respiratory, #Pharmaceutical #ClinicalTrials
San Diego, CA
Joined May 2012
- Tweets1.4K
- Following1.7K
- Followers832
- Likes218
Patrick Hankey, Ph.D retweeted
“Surviving COVID-19: The most important test may be at your fingertips” via @thehill https://teapawt.net/t.co/cKLKUqUhoa
#pulseoximetry
Patrick Hankey, Ph.D retweeted
Pateints can stay home for their cardiac care with the Cardea SOLO Heart@Home #ECG Test Kit. #COVID19 #flattenthecurve #telehealth #telemedicine #afib gosolo.cardiacinsightinc.com…
Patrick Hankey, Ph.D retweeted
Digital Biomarker Development Process for Drug Efficacy Clinical Trial #biomarkers #vivosense ow.ly/yJ6950xT0Qe
Patrick Hankey, Ph.D retweeted
Cardiac Insight is so proud to be ranked 13th in this year's 100 Fastest Growing Private Companies List! #psbj100 #cardiacinsight #cardeasolo
The company’s revenue increased from $677,000 in 2016 to $1.8 million last year, and its sales have increased 100 percent year over year during that time, said CEO Brad Harlow bizjournals.com/seattle/news…
Patrick Hankey, Ph.D retweeted
A recent study examining the utility & reliability of upper extremity motor activity in nonambulatory patients with #DuchenneMuscularDystrophy concluded the cumulative sum of jerks is a useful #outcomemeasure for nonambulatory #DMD patients. @NCNP_PR
ow.ly/BQgq50v1ZPu
Patrick Hankey, Ph.D retweeted
Next week at #IMPACCT, Jeremy Wyatt, ActiGraph President, will join thought leaders from @pfizer, @Sunovion & @abbvie to discuss the role of #digitalinnovation within the changing #clinicalresearch paradigm. @mHealth_Trials ow.ly/HsJw50uXumQ
Patrick Hankey, Ph.D retweeted
Findings from a recent meta-analysis of 17 studies examining the relationship between anxiety & #sedentary behavior (SB) suggest higher levels of SB are associated with higher levels of #anxiety in child, adolescent & adult populations. @FU_Berlin @UCCS ow.ly/atH750uG6E6
Patrick Hankey, Ph.D retweeted
The ActiGraph team is heading to San Antonio for #SLEEP2019 next week! If you're attending this event, please be sure to visit us at booth #1025! @AASMorg @ResearchSleep
Patrick Hankey, Ph.D retweeted
ActiGraph is pleased to announce a new partnership with data analytics specialist @vivosense, which will enhance sponsor access to secure, regulated, analyzed, and contextualized sensor data from clinical trial patients. ow.ly/ScO150umtwX
Patrick Hankey, Ph.D retweeted
Is your #ECG patch living up to its promises?
Discover the advantages of going SOLO: https://teapawt.net/t.co/ASV2kygRxM.
Patrick Hankey, Ph.D retweeted
Our Vice President of Marketing and Business Development, Ann Demaree, shares a personal story about her father to underscore why we shouldn't overlook the ‘gift’ of better health: https://teapawt.net/t.co/RwmEOH58fT.
#medtech #wearables #health #hearthealth
Patrick Hankey, Ph.D retweeted
In my on-boarding to Congress, I get to pick my insurance plan.
As a waitress, I had to pay more than TWICE what I’d pay as a member of Congress.
It’s frustrating that Congressmembers would deny other people affordability that they themselves enjoy. Time for #MedicareForAll.
Patrick Hankey, Ph.D retweeted
Blog: New Resources, Training Help Clinicians Better Interpret ECGs for Athletes | DAIC https://teapawt.net/t.co/Z0s1Vu98Jc @UWSportsCardio @StanfordMed @CardiacInsight #AFib #CardiacMonitoring #AtrialFibrillation
Patrick Hankey, Ph.D retweeted
“She wore it for seven days & she forgot she had it on," states Robert Hauser, M.D., #FACC, #FHRS regarding #CardeaSOLO. Hauser is the sr. consulting #cardiologist at Minneapolis Heart Institute & chair of @CardiacInsight's Scientific Advisory Board. More➡️https://teapawt.net/t.co/jZvVZ6MWVx
Patrick Hankey, Ph.D retweeted
Keep up with #CardeaSOLO.
Join the growing number of professionals who are choosing our industry-first #ECG #wearable when it comes to delivering fast, accurate #cardiac #diagnostic care: lnkd.in/dhvn6gf. #medtech #mednews #technews #wearables
Patrick Hankey, Ph.D retweeted
Thinking about #cardiac monitoring for your next #clinical project? Learn more about HeartcoR’s capabilities for Phase 3 and Phase 4 trials. ow.ly/2TaL30l7e1b
Patrick Hankey, Ph.D retweeted
When the community needs accurate, fast & mobile heart screenings for student athletes, @CardiacInsight is there. We're honored to loan Cardea 20/20 ECG systems to @WHOWEPLAYFOR for this important cause as we all come together to detect undiagnosed heart conditions in our youth. teapawt.net/WHOWEPLAYFOR/status/10…
Diagnosed with #WPW, Nigeire Poyser is now looking to screen 1,000 student-athletes with us THIS SAT (7/28) 8AM-1PM @Nemours Jacksonville. His story: wolfsonchildrens.com/service…
Patrick Hankey, Ph.D retweeted
HeartcoR's @Patrick_Hankey and CEO Larry Lawson are hard at work at #HRS2018. Come visit us at booth 990!
Patrick Hankey, Ph.D retweeted
Our innovative #cardiacmonitoring technology helps improve #compliance and data capture in #clinicalresearch. Learn more at #OCTWestCoast, booth 51. ow.ly/CR6Q30ijabA


















